دورية أكاديمية
BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics.
| العنوان: | BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics. |
|---|---|
| المؤلفون: | Pan RA; Bone Marrow Transplantation Center of the First Affiliated Hospital and Institute of Hematology and Department of Immunology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215., Wang Y; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Qiu S; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Villalobos-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215., Morris E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Halilovic E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215. Anthony_Letai@dfci.harvard.edu. |
| المصدر: | Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1253-1258. Date of Electronic Publication: 2024 Apr 01. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 1999- : Pavia, Italy : Ferrata Storti Foundation Original Publication: Pavia [etc.] |
| مواضيع طبية MeSH: | Proto-Oncogene Proteins c-bcl-2* , Antineoplastic Agents*/pharmacology, Humans ; Proto-Oncogene Proteins ; Apoptosis ; Peptide Fragments/pharmacology ; Cell Line, Tumor |
| References: | Science. 2011 Nov 25;334(6059):1129-33. (PMID: 22033517) Cell. 2022 Apr 28;185(9):1521-1538.e18. (PMID: 35447071) Cell Death Differ. 2020 Mar;27(3):999-1007. (PMID: 31332296) J Med Chem. 2020 Nov 25;63(22):13762-13795. (PMID: 33146521) Nat Rev Cancer. 2008 Feb;8(2):121-32. (PMID: 18202696) Nat Rev Cancer. 2022 Jan;22(1):45-64. (PMID: 34663943) Nat Rev Mol Cell Biol. 2019 Mar;20(3):175-193. (PMID: 30655609) Oncotarget. 2016 Mar 8;7(10):11500-11. (PMID: 26862853) Cancer Cell. 2017 Jan 9;31(1):142-156. (PMID: 28017613) Cancer Discov. 2014 Mar;4(3):362-75. (PMID: 24346116) Cell. 2015 Feb 26;160(5):977-989. (PMID: 25723171) Cancer Discov. 2022 Feb;12(2):290-292. (PMID: 35140175) Methods. 2013 Jun 1;61(2):156-64. (PMID: 23607990) |
| معلومات مُعتمدة: | P01 CA066996 United States CA NCI NIH HHS; R35 CA242427 United States CA NCI NIH HHS |
| المشرفين على المادة: | 0 (Proto-Oncogene Proteins c-bcl-2) 0 (Proto-Oncogene Proteins) 0 (Antineoplastic Agents) 0 (Peptide Fragments) |
| تواريخ الأحداث: | Date Created: 20231026 Date Completed: 20240403 Latest Revision: 20240716 |
| رمز التحديث: | 20240716 |
| مُعرف محوري في PubMed: | PMC10985422 |
| DOI: | 10.3324/haematol.2023.283060 |
| PMID: | 37881837 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1592-8721 |
|---|---|
| DOI: | 10.3324/haematol.2023.283060 |